Zobrazeno 1 - 10
of 583
pro vyhledávání: '"non-proliferative"'
Publikováno v:
BMC Ophthalmology, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background We aimed to evaluate microaneurysms (MAs) after treatment with anti-vascular endothelial growth factor (anti-VEGF) therapy to understand causes of chronic edema and anti-VEGF resistance. Methods Patients with non-proliferative dia
Externí odkaz:
https://doaj.org/article/beba5247fde0413b8f571d6e0cea07d8
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Diabetic retinopathy (DR) is a serious complication of diabetes featuring abnormal lipid metabolism. However, the specific lipid molecules associated with onset and progression remain unclear. We used a broad-targeted lipidomics approach to
Externí odkaz:
https://doaj.org/article/ed17398087d14a919c7144ff6a5741b3
Autor:
Bin Li, Wahab Hussain, Zhi-Liang Jiang, Jia-Yi Wang, Sarfraz Hussain, Talat Bilal Yasoob, Yuan-Kun Zhai, Xin-Ying Ji, Ya-Long Dang
Publikováno v:
BioMedical Engineering OnLine, Vol 23, Iss 1, Pp 1-17 (2024)
Abstract Diabetic retinopathy (DR) is an eye disease that causes blindness and vision loss in diabetic. Risk factors for DR include high blood glucose levels and some environmental factors. The pathogenesis is based on inflammation caused by interfer
Externí odkaz:
https://doaj.org/article/bee40b1ffeed4b4ba1290c5f56876d10
Autor:
Andrew A. Moshfeghi, Rahul N. Khurana, Hadi Moini, Steven Sherman, Kimberly Reed, Nick Boucher, Ehsan Rahimy
Publikováno v:
BMC Ophthalmology, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background This study evaluated impact of anti–vascular endothelial growth factor (VEGF) treatment on proliferative diabetic retinopathy (PDR) development among patients with non-proliferative diabetic retinopathy (NPDR) in US real-world c
Externí odkaz:
https://doaj.org/article/b98d37a3c435477a8c9f71e77f0d30cf
Publikováno v:
Guoji Yanke Zazhi, Vol 24, Iss 5, Pp 790-794 (2024)
AIM: To investigate the clinical efficacy of the compound anisodine combined with retinal laser photocoagulation in the treatment of severe non-proliferative diabetic retinopathy(NPDR). METHODS: According to the retrospective study, totally 120 eyes
Externí odkaz:
https://doaj.org/article/49fdc4811a5c4cc0a30a5ac69e658d54
Autor:
Samraa Hussain, Naji AlJohani
Publikováno v:
Diabetology, Vol 4, Iss 4, Pp 490-498 (2023)
Aims: To determine the prevalence and predictors of diabetic retinopathy (DR) in Saudi males and females with diabetes. Methods: This cross-sectional study enrolled 507 patients with diabetes between May and August 2018. The data extracted from patie
Externí odkaz:
https://doaj.org/article/6dbba20fd1ef406f9b09bd8942d6124c
Publikováno v:
Guoji Yanke Zazhi, Vol 24, Iss 2, Pp 307-311 (2024)
AIM: To investigate the differences in varying stages of non-proliferative diabetic retinopathy(NPDR)using optical coherence tomography angiography(OCTA).METHODS: Cross-sectional study. A total of 77 cases(77 eyes)of diabetic patients were included,
Externí odkaz:
https://doaj.org/article/25b1d7d4f3984f08a7588641b13696da
Autor:
Khisimusi Debree Maluleke, Cairo Bruce Ntimana, Reneilwe Given Mashaba, Kagiso Peace Seakamela, Eric Maimela
Publikováno v:
Frontiers in Clinical Diabetes and Healthcare, Vol 5 (2024)
BackgroundDiabetic retinopathy (DR) is the major cause of vision impairment or blindness in individuals who have diabetes. It has accounted for 2.6% of all cases of blindness, and 1.9% of all cases of vision impairments globally. There is a lack of d
Externí odkaz:
https://doaj.org/article/2cac6163629e490787b807ec740889b7
Publikováno v:
Data in Brief, Vol 52, Iss , Pp 110033- (2024)
This article presents a Multimodal database consisting of 222 images of 76 people wherein 111 are OCTA images and 111 are color fundus images taken at the Natasha Eye Care and Research Institute of Pune Maharashtra, India. Nonmydriatic fundus images
Externí odkaz:
https://doaj.org/article/19bee6e7d23f44e7a319ed93456cf081
Publikováno v:
Zhongguo linchuang yanjiu, Vol 36, Iss 5, Pp 656-660 (2023)
Objective To explore the associations of triglyceride-glucose（TyG） index with the degree of non-proliferative diabetic retinopathy（NPDR） in patients with type 2 diabetes mellitus（T2DM）. Methods The clinical data and laboratory results of
Externí odkaz:
https://doaj.org/article/c7345ac0ffb04ba5815e50dcb6e0d727